Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Journal of Personalized Medicine|October 23, 2021
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular CarcinomaAlessandro Granito, Antonio Facciorusso, Rodolfo Sacco, et al.
Liver Cancer|June 11, 2025
The Concept of "Converse Therapeutic Hierarchy" for Patients with Hepatocellular CarcinomaAlessandro Vitale, Giuseppe Cabibbo, Lorenza Rimassa, et al.
Journal of Hepatocellular Carcinoma|March 23, 2026
HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic PatientsMadalina-Gabriela Indre, Bernardo Stefanini, Maria Boe, et al.
Magnetic Resonance Imaging|September 14, 2020
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liverMatteo Renzulli, Stefano Brocchi, Anna Maria Ierardi, et al.
Clinical and Translational Gastroenterology|January 14, 2021
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With SorafenibVito Sansone, Francesco Tovoli, Andrea Casadei-Gardini, et al.
Future Oncology (London, England)|August 10, 2018
Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life studyRodolfo Sacco, Alessandro Granito, Irene Bargellini, et al.
Cancers|November 3, 2020
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic RoleStefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, et al.
Internal and Emergency Medicine|March 29, 2024
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenibBernardo Stefanini, Francesco Tovoli, Franco Trevisani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2025
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life StudyLeonardo Stella, Maria Pallozzi, Lucia Cerrito, et al.
Pageof 13